Immuron (IMRN) Total Current Liabilities (2016 - 2025)

Immuron (IMRN) posted quarterly Total Current Liabilities of $19662.1 for Q3 2025, down 27.15% year-on-year from $26989.8 in Q3 2024, and down 98.58% on a QoQ basis from $1.4 million in Q2 2025.

Immuron (IMRN) Total Current Liabilities (2016 - 2025) Analysis & Trends

Immuron (IMRN) has reported Total Current Liabilities for 10 consecutive years, with $19662.1 the latest figure, recorded in Q3 2025.

  • Quarterly Total Current Liabilities fell 27.15% year-over-year to $19662.1 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19662.1 (down 27.15% YoY) and the FY2025 annual result came in at $19662.1, down 27.15% from the prior year.
  • Total Current Liabilities declined to $19662.1 in Q3 2025 per IMRN's latest filing, from $1.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for IMRN reached as high as $2.2 million in Q2 2023 and fell as low as $15706.0 in Q4 2023.
  • A 5-year average of $939665.7 and a median of $1.1 million in 2022 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 16055.14% — and 2023, when it sank 98.52%.
  • Year by year, Total Current Liabilities stood at $792280.3 in 2021, then surged by 33.97% to $1.1 million in 2022, then plunged by 98.52% to $15706.0 in 2023, then surged by 7673.27% to $1.2 million in 2024, then slumped by 98.39% to $19662.1 in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $19662.1, $1.4 million, and $1.2 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Immuron 270.20 Mn 258.54 Mn - 19,662.09

Historic Data

Download Data
DateValue
Sep 2, 2025 19,662.09
Jun 30, 2025 1.39 Mn
Dec 31, 2024 1.22 Mn
Sep 9, 2024 26,989.79
Jun 30, 2024 1.91 Mn
Dec 31, 2023 15,706.03
Sep 28, 2023 1.57 Mn
Aug 30, 2023 22,191.39
Jun 30, 2023 2.22 Mn
Dec 31, 2022 1.06 Mn
Aug 31, 2022 1.06 Mn
Jun 30, 2022 1.06 Mn
Dec 31, 2021 792,280.27
Jun 30, 2021 792,280.27
Dec 31, 2020 4,904.20
Sep 1, 2020 516,411.00
Jun 30, 2020 364,702.19
Dec 31, 2019 5,164.11
Jun 30, 2019 1.20 Mn
Dec 31, 2018 803,338.00